FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Music and patriotism: Dukes of Hazzard star praises community and family at Great American State Fair

Tyler Robinson preliminary hearing: Judge orders redactions to ex-lover’s video testimony

Social media influencer and model, 22, killed in violent highway crash

Trump threatens troop withdrawals if ‘very good deal’ on Greenland isn’t struck

Stepdad accused of sex assault as cops widen probe into girl’s lethal Benadryl ingredient dose

More than 30 injured after Maryland transit bus crashes into building near Baltimore

House Dem back in the spotlight as brother faces up to 10 years in prison if convicted

Platner drops out of crucial Senate race after bombshell rape allegation torpedoes campaign

Franklin Graham Gives McDonald’s ‘Free Advice’ on How to ‘Bring Happy Customers Back’

Who is Valli Geiger? Meet the Maine Dem that Platner urged to run for Senate

Mike Rowe Sues Discovery for $2 Million in ‘Deadliest Catch’ Dispute

Erika’s Heartbreaking Reaction to a Woman She Saw in the Courtroom Crying Over Charlie’s Murder

Former Wisconsin Judge Who Was Convicted of Helping an Illegal Alien Evade ICE Gets Light Sentence

Bernie-backed socialist who allied with Platner could supplant him on ballot

WATCH: Dana White drops 2028 hints while raving about his favorite Trump cabinet secretary

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”